Cargando…
Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies
SIMPLE SUMMARY: Reprogramming of glucose metabolism is a hallmark of cancer and can be targeted by therapeutic agents. Some metabolism regulators, such as ivosidenib and enasidenib, have been approved for cancer treatment. Currently, more advanced and effective glucose metabolism enzyme-targeted ant...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559313/ https://www.ncbi.nlm.nih.gov/pubmed/36230492 http://dx.doi.org/10.3390/cancers14194568 |